As of Apr 28
| +0.12 / +0.58%|
The 2 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 55.00, with a high estimate of 70.00 and a low estimate of 40.00. The median estimate represents a +165.83% increase from the last price of 20.69.
The current consensus among 2 polled investment analysts is to Buy stock in Albireo Pharma Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.